Back
BioCryst Pharmaceuticals, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
59
BCRX
BioCryst Pharmaceuticals, Inc.
Last Price:
$7.84
Seasonality Move:
8.4%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiBioCryst Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, BioCryst Pharmaceuticals, Inc. has on average historically risen by 55.4% based on the past 31 years of stock performance.
-
BioCryst Pharmaceuticals, Inc. has risen higher in 14 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.16%
-
Is BioCryst Pharmaceuticals, Inc. Stock Undervalued?The current BioCryst Pharmaceuticals, Inc. [BCRX] share price is $7.83. The Score for BCRX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
BCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will BioCryst Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, BioCryst Pharmaceuticals, Inc. has on average historically risen by 55.4% based on the past 31 years of stock performance.
BioCryst Pharmaceuticals, Inc. Stock Rating
Buy
59
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Buy
Is BioCryst Pharmaceuticals, Inc. overpriced?
-
BioCryst Pharmaceuticals, Inc. has risen higher in 14 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.16%
BioCryst Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biocryst.com
52-Week Data
52-Week High:
11.31
52-Week Low:
6.00
Prediction Charts
Market Cap:
1.6B
Price in USD:
7.83
Volume:
6.7M
Beta:
1.66
Technical Analysis
SMA50:
7.14
SMA100:
7.70
SMA200:
8.31
52-Wk Change:
6.82%
Stock Predictions
-
Is BioCryst Pharmaceuticals, Inc. stock public?Yes, BioCryst Pharmaceuticals, Inc. is a publicly traded company.
-
What is the BioCryst Pharmaceuticals, Inc. stock quote today?The BioCryst Pharmaceuticals, Inc. stock price is 7.83 USD today.
-
How to buy BioCryst Pharmaceuticals, Inc. stock online?You can buy BioCryst Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 6.88 | 7.08 | 7.19 | 6.85 |
| Nov-17 | 7.10 | 7.03 | 7.21 | 7.00 |
| Nov-18 | 7.00 | 7.00 | 7.13 | 6.97 |
| Nov-19 | 7.01 | 6.93 | 7.07 | 6.73 |
| Nov-20 | 7.04 | 7.03 | 7.09 | 6.89 |
| Nov-21 | 7.03 | 6.97 | 7.17 | 6.95 |
| Nov-24 | 7.00 | 6.83 | 7.05 | 6.71 |
| Nov-25 | 6.91 | 6.85 | 7.01 | 6.71 |
| Nov-26 | 6.85 | 7.10 | 7.14 | 6.81 |
| Nov-28 | 7.12 | 7.18 | 7.23 | 7.05 |
| Dec-1 | 7.08 | 7.13 | 7.20 | 7.02 |
| Dec-2 | 7.17 | 7.16 | 7.30 | 7.12 |
| Dec-3 | 7.11 | 7.85 | 7.88 | 7.11 |
| Dec-4 | 7.85 | 7.83 | 8.17 | 7.79 |
BioCryst Pharmaceuticals, Inc. Earnings
BioCryst Pharmaceuticals, Inc. Earnings Report: Per Share BioCryst Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioCryst Pharmaceuticals, Inc. Forecast Revenue Growth
BioCryst Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for BioCryst Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and a decrease next year of $0.04 per share.
* BioCryst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.